Meta-analysis of randomized, controlled trials comparing particular doses of griseofulvin and terbinafine for the treatment of tinea capitis

Pediatric Dermatology

Volumn 30, Issue 1, 2013, Pages 1-6

  Gupta, Aditya K ^a   Drummond Main, Chris ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b MEDIPROBE RESEARCH INC   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GRISEOFULVIN; TERBINAFINE;

ARTICLE; DRUG EFFICACY; DRUG RESPONSE; FUNGUS CULTURE; HUMAN; META ANALYSIS; MICROSPORUM; PRIORITY JOURNAL; TINEA CAPITIS; TREATMENT DURATION; TRICHOPHYTON;

ADMINISTRATION, ORAL; ANTIFUNGAL AGENTS; CONFIDENCE INTERVALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; GRISEOFULVIN; HUMANS; MALE; NAPHTHALENES; ODDS RATIO; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TIME FACTORS; TINEA CAPITIS; TREATMENT OUTCOME; TRICHOPHYTON;

EID: 84872352116     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2012.01866.x     Document Type: Article

References (19)

1. Gupta AK, Summerbell RC,. Tinea capitis. Med Mycol 2000; 38: 255-287.
2. Caceres-Rios H, Rueda M, Ballona R, et al., Comparison of terbinafine and griseofulvin in the treatment of tinea capitis. J Am Acad Dermatol 2000; 42: 80-84.
3. Memisoglu HR, Erboz S, Akkaya S, et al., Comparative study of the efficacy and tolerability of 4 weeks of terbinafine therapy with 8 weeks of griseofulvin therapy in children with tinea capitis. J Dermatol Treat 1999; 10: 189-193.
4. Fuller LC, Smith CH, Cerio R, et al., A randomized comparison of 4 weeks of terbinafine vs. 8 weeks of griseofulvin for the treatment of tinea capitis. Br J Dermatol 2001; 144: 321-327.
5. Elewski BE, Caceres HW, DeLeon L, et al., Terbinafine hydrochloride oral granules versus oral griseofulvin suspension in children with tinea capitis: results of two randomized, investigator-blinded, multicenter, international, controlled trials. J Am Acad Dermatol 2008; 59: 41-54.
6. Lipozencic J, Skerlev M, Orofino-Costa R, et al., A randomized, double-blind, parallel-group, duration-finding study of oral terbinafine and open-label, high-dose griseofulvin in children with tinea capitis due to Microsporum species. Br J Dermatol 2002; 146: 816-823.
7. Gupta AK, Adam P, Dlova N, et al., Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazole. Pediatr Dermatol 2001; 18: 433-438.
8. Rademaker M, Havill S,. Griseofulvin and terbinafine in the treatment of tinea capitis in children. N Z Med J 1998; 111: 55-57.
9. Haroon TS, Hussain I, Aman S, et al., A randomized double-blind comparative study of terbinafine and griseofulvin in tinea capitis. J Dermatol Treat 1995; 6: 167-169.
10. Fleece D, Gaughan JP, Aronoff SC,. Griseofulvin versus terbinafine in the treatment of tinea capitis: a meta-analysis of randomized, clinical trials. Pediatrics 2004; 114: 1312-1315.
11. Gonzalez U, Seaton T, Bergus G, et al., Systemic antifungal therapy for tinea capitis in children. Cochrane Database Syst Rev 2007; 17: CD004685.
12. Tey HL, Tan AS, Chan YC,. Meta-analysis of randomized, controlled trials comparing griseofulvin and terbinafine in the treatment of tinea capitis. J Am Acad Dermatol 2011; 64: 663-670.
13. Elewski BE,. Tinea capitis: a current perspective. J Am Acad Dermatol 2000; 42: 1-20; quiz 21-24.
14. Roberts BJ, Friedlander SF,. Tinea capitis: a treatment update. Pediatr Ann 2005; 34: 191-200.
15. Lamisil prescribing information [on-line]. http://www.pharma.us.novartis. com/product/pi/pdf/Lamisil-Oral-Granules.pdf. Accessed March 3, 2011.
16. Nejjam F, Zagula M, Cabiac MD, et al., Pilot study of terbinafine in children suffering from tinea capitis: evaluation of efficacy, safety and pharmacokinetics. Br J Dermatol 1995; 132: 98-105.
17. Abdel-Rahman SM, Herron J, Fallon-Friedlander S, et al., Pharmacokinetics of terbinafine in young children treated for tinea capitis. Pediatr Infect Dis J 2005; 24: 886-891.
18. Higgins EM, Fuller LC, Smith CH,. Guidelines for the management of tinea capitis. British Association of Dermatologists. Br J Dermatol 2000; 43: 53-58.
19. Gupta AK, Cooper EA,. Update in antifungal therapy of dermatophytosis. Mycopathologia 2008; 66: 353-367.